Wednesday, July 8, 2026

Drug profile · INN

sodium acetate

sodium acetate (SODIUM ACETATE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — sodium acetate
US status
approved
Class
Route
INTRAVENOUS
Patents
0
Programs
3
Data quality
0.89

Quick answer

sodium acetate (SODIUM ACETATE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN sodium acetate
Brand SODIUM ACETATE
Route INTRAVENOUS
Formulation SOLUTION

Approval history

Authority Status Date
FDA approved

Pipeline programs

  1. DTX301-CL301 Phase 3 · Anaxis Pharma · Late-onset Ornithine transcarbamylase (OTC) deficiency
  2. JSP-CP-011 Phase 2 · Jasper Therapeutics · Chronic Spontaneous Urticaria
  3. CPS-101 Phase 1 · Camp4 Therapeutics · Urea cycle disorders (UCD)

Frequently asked questions

What is sodium acetate?

sodium acetate (SODIUM ACETATE) is an FDA-listed pharmaceutical active ingredient. Associated with Amneal Pharma Europe Ltd. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for sodium acetate?

SODIUM ACETATE is a marketed brand name for sodium acetate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium acetate?

sodium acetate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.